QuickView for HTR6;jsessionid=758F30BF593C190084013F5D5D186CAB;jsessionid=601A16B1ED81EC7C18A4D719D5D2A0AD;jsessionid=7782EAA0EB4752C800C4CCDA830A11C0;jsessionid=FBF1C2BCE1FAB38D3D7240A912E65F6E;jsessionid=44F8CAE75AE90E6C22FD0ABA196A7647 (gene)

1. Structural insight into the selective agonist ST1936 binding of serotonin receptor 5-HT6.
2. An exit beyond the pharmacophore model for 5-HT6R agents - a new strategy to gain dual 5-HT6/5-HT2A …
3. 5-HT6R null mutatrion induces synaptic and cognitive defects.
4. N-Skatyltryptamines-Dual 5-HT6R/D2R Ligands with Antipsychotic and Procognitive Potential.
5. HTR6 and SSTR3 targeting to primary cilia.

There were no clinical trials for HTR6;jsessionid=758F30BF593C190084013F5D5D186CAB;jsessionid=601A16B1ED81EC7C18A4D719D5D2A0AD;jsessionid=7782EAA0EB4752C800C4CCDA830A11C0;jsessionid=FBF1C2BCE1FAB38D3D7240A912E65F6E;jsessionid=44F8CAE75AE90E6C22FD0ABA196A7647